Search Results - "Van Der Linden, Michiel W."

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
  2. 2
  3. 3

    Topical Corticosteroids and the Risk of Diabetes Mellitus: A Nested Case-Control Study in the Netherlands by van der Linden, Michiel W., Beest, Fernie J. A. Penning-van, Nijsten, Tamar, Herings, Ron M. C.

    Published in Drug safety (01-01-2009)
    “…Background: The relationship between topical corticosteroid use, potency, treatment duration, concomitant exposure to systemic corticosteroids, and risk of…”
    Get full text
    Journal Article
  4. 4

    Prevalence estimates of asthma or COPD from a health interview survey and from general practitioner registration: what's the difference? by Mohangoo, Ashna D., van der Linden, Michiel W., Schellevis, François G., Raat, Hein

    Published in European journal of public health (01-02-2006)
    “…Background: The aim of this study was to compare prevalence estimates of asthma or chronic obstructive pulmonary disease (COPD) derived from self-report in a…”
    Get full text
    Journal Article
  5. 5

    Large Impact of Antidiabetic Drug Treatment and Hospitalizations on Economic Burden of Diabetes Mellitus in The Netherlands during 2000 to 2004 by van der Linden, Michiel W., MD, PhD, Plat, Arian W., MSc, Erkens, Joelle A., PharmD, PhD, Emneus, Martha, MSc, Herings, Ron M.C., PhD

    Published in Value in health (01-09-2009)
    “…ABSTRACT Objective To estimate the burden of diabetes mellitus (DM) and its complications in The Netherlands. Methods The PHARMO Record Linkage System…”
    Get full text
    Journal Article
  6. 6

    Increasing incidence of skin disorders in children? A comparison between 1987 and 2001 by Mohammedamin, Robbert S A, van der Wouden, Johannes C, Koning, Sander, van der Linden, Michiel W, Schellevis, François G, van Suijlekom-Smit, Lisette W A, Koes, Bart W

    Published in BMC dermatology (21-03-2006)
    “…The increasing proportion of skin diseases encountered in general practice represents a substantial part of morbidity in children. Only limited information is…”
    Get full text
    Journal Article
  7. 7

    Gastroprotection among new chronic users of non-steroidal anti-inflammatory drugs: a study of utilization and adherence in the Netherlands by Van der Linden, Michiel W., Gaugris, Sabine, Kuipers, Ernst J., Van den Bemt, Bart J. F., van Herk-Sukel, Myrthe P. P., Herings, Ron M. C.

    Published in Current medical research and opinion (01-01-2009)
    “…ABSTRACT Objective: To describe the use of gastroprotection (GP) among new chronic users of NSAIDs in the Netherlands by gastrointestinal (GI) risk factor (RF)…”
    Get full text
    Journal Article
  8. 8

    Development of a case-based system for grouping diagnoses in general practice by Biermans, Marion C.J, de Bakker, Dinny H, Verheij, Robert A, Gravestein, Jan V, van der Linden, Michiel W, de Vries Robbé, Pieter F

    “…Abstract Introduction This article describes the development of EPICON; an application to group ICPC-coded diagnoses from electronic medical records in general…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawal by Sukel, Myrthe P. P., van der Linden, Michiel W., Chen, Connie, Erkens, Joëlle A., Herings, Ron M. C.

    Published in Pharmacoepidemiology and drug safety (01-01-2008)
    “…Purpose To compare treatment changes after the rofecoxib withdrawal with changes occurring normally and to re‐assess 12 months afterwards. Methods The PHARMO…”
    Get full text
    Journal Article
  13. 13

    LDL-C reductions and goal attainment among naive statin users in the Netherlands: real life results by Heintjes, Edith M., Hirsch, Mark W., van der Linden, Michiel W., O‘Donnell, John C., Stalenhoef, Anton F., Herings, Ron M. C.

    Published in Current medical research and opinion (01-08-2008)
    “…ABSTRACT Objective: The effectiveness of statin therapy in a real life setting may differ from that in clinical trials, as physicians make non-randomised…”
    Get full text
    Journal Article
  14. 14

    Determination of tumour necrosis factor-α and interleukin-10 production in a whole blood stimulation system: assessment of laboratory error and individual variation by van der Linden, Michiel W, Huizinga, Tom W.J, Stoeken, Dirk-Jan, Sturk, Augueste, Westendorp, Rudi G.J

    Published in Journal of immunological methods (01-09-1998)
    “…Ex vivo production of cytokines as determined by whole blood stimulation and supernatant ELISA is partly determined by heritability. To assess the ability of…”
    Get full text
    Journal Article
  15. 15

    The association between H63D mutations in HFE and amyotrophic lateral sclerosis in a Dutch population by Sutedja, Nadia A, Sinke, Richard J, Van Vught, Paul W J, Van der Linden, Michiel W, Wokke, John H J, Van Duijn, Cornelia M, Njajou, Omer T, Van der Schouw, Yvonne T, Veldink, Jan H, Van den Berg, Leonard H

    Published in Archives of neurology (Chicago) (01-01-2007)
    “…Mutations in HFE, a gene defect that can disrupt iron metabolism, have been implicated in increasing the risk of developing amyotrophic lateral sclerosis…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Autoantibodies within families of patients with systemic lupus erythematosus are not directed against the same nuclear antigens by VAN DER LINDEN, Michiel W, WESTENDORP, Rudi G. J, ZIDANE, Majida, MEHEUS, Lydie, HUIZINGA, Tom W. J

    Published in Journal of rheumatology (01-02-2001)
    “…OBJECTIVE: The presence of antinuclear autoantibodies in systemic lupus erythematosus (SLE) is influenced by genetic factors. The presence of autoantibodies in…”
    Get full text
    Journal Article Conference Proceeding
  18. 18
  19. 19